David (Dedi) Meiri, PhD
David (Dedi) Meiri, PhD, is an Assistant Professor at the Faculty of Biology at the Technion Israel Institute of Technology and a member of the Technion Integrated Cancer Center (TICC). Dr. Meiri's scientific background is highly diverse. He holds a M.Sc. in biochemistry and a Ph.D. in plant biotechnology from Tel Aviv University. Dr. Meiri conducted his post-doctoral fellowship at the Ontario Cancer Institute where he focusedon the role of the GEF-H1protein in tumor invasion and metastasis. During his post-doctoral studies, he expanded his knowledge in human biology and cancer pathogenesis. Upon completion of his post-doctoral fellowship, Dr. Meiri took a position at the Technion Israel Institute of Technology, where he heads the "Laboratory of Cancer Biology and Cannabinoid Research".
From the establishment of his lab it has grown significantly and it is now comprised of 38 scientists. Meiri's highly trained team of skilled plant biologists, chemists, cancer experts and neuroscientists work together in synergy to complement one another in orderto achieve the highest level of results.
All together Meiri's lab is today one of the leading laboratories in the worldthat is exceptionally equipped with the capabilities and resources to ask and answer almost any question in the field of medical cannabis. It is a "holistic" lab which can perform "in house" almost every experiment related to medical cannabis.
Presently, his lab investigates thetherapeutic potential of phytocannabinoids, the unique active compounds of the Cannabis sativaplant. On top of other research being conducted in the lab, the main focus of his research is to determine the antitumor effects of cannabinoids, including theanti-metastatic and pro-apoptotic effects of phytocannabinoids.
In addition to the laboratory cannabis research performed on-site, Dr. Meiri collaborates with cannabis growers, clinicians, major manufacturers and distributors of medical cannabisfor the purpose of revolutionizing cannabis treatment. He is operating the "Cannabis Database Project" and his lab is currently involved in eight clinical trials covering diverse aspects of cannabis treatment such as colon disease, pain prevention, cancer treatment and epilepsy.
Dr. Meiri is also highly involved in governmental regulations and is a residing member in several Israeli Ministry of Health committees which seek to advance the fundamental understanding of optimal cannabis usage and minimization of adverse side effects.
David (Dedi) Meiri, Ph.D
Head, Laboratory of Cancer Biology and Cannabinoid Research
Faculty of Biology and Technion Integrated Cancer Center
Technion-Israel Institute of Technology,
Haifa, 320003 Israel
Tel: +972-77-8871680Tel: +972-52-5330031